HIV Infections Clinical Trial
Official title:
An Open Label Safety Study to Evaluate the Safety of Tipranavir Plus Ritonavir When Used in Combination With Other Agents for the Treatment of Patients With HIV Infection Who Have Failed and/or Are Intolerant to Combination Antiretroviral Therapy and Have Limited Treatment Options
To provide early access to tipranavir and evaluate the safety and tolerance of tipranavir combined with low dose of ritonavir in patients with progressive, HIV-1 disease who have failed or are intolerant to currently approved treatments for HIV infection, who are unable to participate in another tipranavir controlled clinical trial and have an urgent need for anti-HIV treatment.
| Status | Approved for marketing |
| Enrollment | 0 |
| Est. completion date | April 2014 |
| Est. primary completion date | April 2014 |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | 2 Years and older |
| Eligibility |
Inclusion criteria: Patients aho have a positive serology HIV antibody test confirmed by Western blot, p24 antigen assay, HIV-1 RNA or HIV culture and are highly pre-treated and virus resistant to multiple protease inhibitors. |
N/A
| Country | Name | City | State |
|---|---|---|---|
| Australia | 1182.58.61020 | Adelaide | South Australia |
| Australia | 1182.58.61015 Flinders Medical Centre | Bedford Park | South Australia |
| Australia | 1182.58.61010 Biala Building | Brisbane | Queensland |
| Australia | 1182.58.61005 Royal Prince Alfred Hospital | Camperdown | New South Wales |
| Australia | 1182.58.61001 88 Rathdowne Street Carlton | Carlton | Victoria |
| Australia | 1182.58.61018 Melbourne Sexual Health Clinic | Carlton | Victoria |
| Australia | 1182.58.61017 Department of Infectious Diseases | Clayton | Victoria |
| Australia | 1182.58.61008 St Vincents Hospital | Darlinghurst | New South Wales |
| Australia | 1182.58.61011 St Vincents Hospital | Darlinghurst | New South Wales |
| Australia | 1182.58.61014 St Vincents Hospital | Darlinghurst | New South Wales |
| Australia | 1182.58.61007 407 Doctors Pty Ltd | Darlinghusrst | New South Wales |
| Australia | 1182.58.61019 407 Bouke Street | Darlinghusrst | New South Wales |
| Australia | 1182.58.61009 Level 6 | Herston | Queensland |
| Australia | 1182.58.61022 Sexual Health Clinic | Kingswood | New South Wales |
| Australia | 1182.58.61012 Bigge Park Centre | Liverpool | New South Wales |
| Australia | 1182.58.61013 Melbourne Sexual Health Clinic | Melbourne | Victoria |
| Australia | 1182.58.61023 | Melbourne | Victoria |
| Australia | 1182.58.61024 | Nambour | Queensland |
| Australia | 1182.58.61004 Royal Perth Hospital | Perth | Western Australia |
| Australia | 1182.58.61003 The Prince of Wales Hospital | Randwick | New South Wales |
| Australia | 1182.58.61021 | South Yarra | Victoria |
| Australia | 1182.58.61002 Royal North Shore Hospital | St Leonards | New South Wales |
| Australia | 1182.58.61006 Albion Street Clinic | Surry Hills | New South Wales |
| Australia | 1182.58.61025 Immunology Department | Westmead | New South Wales |
| Australia | 1182.58.61016 Princess Alexandra Hospital | Woolloongabba | Queensland |
| Belgium | 1182.58.3201 Boehringer Ingelheim Investigational Site | Antwerpen | |
| Belgium | 1182.58.3202 Boehringer Ingelheim Investigational Site | Bruxelles | |
| Belgium | 1182.58.3203 Boehringer Ingelheim Investigational Site | Bruxelles | |
| Belgium | 1182.58.3204 Boehringer Ingelheim Investigational Site | Liège | |
| Denmark | 1182.58.4505 Aarhus Universitetshospital Skejby | Aarhus C | |
| Denmark | 1182.58.4501 Rigshospitalet | København Ø | |
| Denmark | 1182.58.4504 Odense Universitetshospital | Odense C | |
| France | 1182.58.33029 Hôpital Aix | Aix en Provence cedex 1 | |
| France | 1182.58.33001 Hôpital Saint Jacques | Besançon cedex | |
| France | 1182.58.33022 Hôpital Avicenne | Bobigny cedex | |
| France | 1182.58.33020 Hôpital Antoine Beclère | Clamart cedex | |
| France | 1182.58.33028 Hôpital Louis Mourier | Colombes | |
| France | 1182.58.33027 Hôpital | Dijon cedex | |
| France | 1182.58.33034 Hôpital Raymond Poincarré | Garches | |
| France | 1182.58.33006 Hôpital Bicêtre | Le Kremlin Bicêtre cedex | |
| France | 1182.58.33019 Hôpital de l'Hôtel Dieu | Lyon cedex 2 | |
| France | 1182.58.33031 Hôpital edouard Herriot | Lyon cedex 3 | |
| France | 1182.58.33009 Hôpital de la Conception | Marseille cedex 5 | |
| France | 1182.58.33023 Hôpital Sainte Marguerite | Marseille cedex 9 | |
| France | 1182.58.33030 Hôpital Saint Eloi | Montpellier | |
| France | 1182.58.33032 Hôpital Emile Muller | Mulhouse cedex 1 | |
| France | 1182.58.33008 Hôpital Hôtel Dieu | Nantes cedex 1 | |
| France | 1182.58.33003 Hôpital de l'Archet | Nice cedex 3 | |
| France | 1182.58.33018 Hôpital Saint Antoine | Paris | |
| France | 1182.58.33024 Hôpital Necker | Paris | |
| France | 1182.58.33013 Hôpital Saint Louis | Paris cedex 10 | |
| France | 1182.58.33014 Hôpital Cochin | Paris cedex 14 | |
| France | 1182.58.33007 Hôpital Georges Pompidou | Paris cedex 15 | |
| France | 1182.58.33005 Hôpital Bichat | Paris cedex 18 | |
| France | 1182.58.33017 Hôpital Bichat Claude Bernard | Paris cedex 18 | |
| France | 1182.58.33033 Hôpital Tenon | Paris cedex 20 | |
| France | 1182.58.33035 Hôpital des Abîmes | Pointe A Pitre | |
| France | 1182.58.33012 Hôpital Robert Debré | Reims cedex | |
| France | 1182.58.33026 Hôpital Ponchaillou | Rennes cedex 9 | |
| France | 1182.58.33015 Hôpital Civil | Strasbourg cedex | |
| France | 1182.58.33025 Hôpital Foch | Suresnes cedex | |
| France | 1182.58.33021 Hôpital Chalucet | Toulon cedex | |
| France | 1182.58.33002 Hôpital Purpan | Toulouse cedex 9 | |
| France | 1182.58.33016 | Tourcoing | |
| France | 1182.58.33010 Hôpital Brabois | Vandoeuvre Les Nancy | |
| France | 1182.58.33011 Hôpital Paul Brousse | Villejuif cedex | |
| Greece | 1182.58.3001 | Athens | |
| Ireland | 1182.58.44016 St James Hospital, Dept of Genito Urinary Medicine | Dublin | |
| Ireland | 1182.58.44029 Our Lady For Sick Children | Dublin 12 | |
| Italy | 1182.58.3903 Università di Brescia | Brescia | |
| Italy | 1182.58.3904 Ospedali Riuniti di Foggia | Foggia | |
| Italy | 1182.58.3901 Ospedale Luigi Sacco | Milano | |
| Italy | 1182.58.3902 Ospedale L. Sacco | Milano | |
| Italy | 1182.58.3907 Presidio Ospedaliero di Rimini | Rimini | |
| Italy | 1182.58.3905 Presidio Dalmati | S. Angelo Lodigiano (lo) | |
| Italy | 1182.58.3906 Ospedale Infantile Regina Margherita | Torino | |
| Italy | 1182.58.3908 Centro Medicina Preventiva | Verona | |
| Portugal | 1182.58.35102 Hospital Condes Castro Guimarães | Cascais | |
| South Africa | 1182.58.27095 Boehringer Ingelheim Investigational Site | Cape Town | |
| South Africa | 1182.58.27098 Boehringer Ingelheim Investigational Site | Cape Town | |
| South Africa | 1182.58.27099 Boehringer Ingelheim Investigational Site | Cape Town | |
| South Africa | 1182.58.27096 Boehringer Ingelheim Investigational Site | Durban | |
| South Africa | 1182.58.27097 Boehringer Ingelheim Investigational Site | Westville, Durban | |
| Switzerland | 1182.58.4101 Boehringer Ingelheim Investigational Site | Basel | |
| Switzerland | 1182.58.4103 Boehringer Ingelheim Investigational Site | Bern | |
| Switzerland | 1182.58.4104 Boehringer Ingelheim Investigational Site | Genève | |
| Switzerland | 1182.58.4107 Boehringer Ingelheim Investigational Site | Genève | |
| Switzerland | 1182.58.4102 Boehringer Ingelheim Investigational Site | Zürich | |
| Switzerland | 1182.58.4105 Boehringer Ingelheim Investigational Site | Zürich | |
| United Kingdom | 1182.58.44020 Beckenham Hospital | Beckenham | |
| United Kingdom | 1182.58.44004 Boehringer Ingelheim Investigational Site | Brighton | |
| United Kingdom | 1182.58.44002 Boehringer Ingelheim Investigational Site | Cardiff | |
| United Kingdom | 1182.58.44025 Boehringer Ingelheim Investigational Site | Chertsey | |
| United Kingdom | 1182.58.44019 Boehringer Ingelheim Investigational Site | Chichester | |
| United Kingdom | 1182.58.44009 Boehringer Ingelheim Investigational Site | Edinburgh | |
| United Kingdom | 1182.58.44023 Boehringer Ingelheim Investigational Site | Harrow | |
| United Kingdom | 1182.58.44024 Boehringer Ingelheim Investigational Site | Leeds | |
| United Kingdom | 1182.58.44003 Boehringer Ingelheim Investigational Site | London | |
| United Kingdom | 1182.58.44005 Boehringer Ingelheim Investigational Site | London | |
| United Kingdom | 1182.58.44008 Boehringer Ingelheim Investigational Site | London | |
| United Kingdom | 1182.58.44010 Boehringer Ingelheim Investigational Site | London | |
| United Kingdom | 1182.58.44014 Boehringer Ingelheim Investigational Site | London | |
| United Kingdom | 1182.58.44017 Boehringer Ingelheim Investigational Site | London | |
| United Kingdom | 1182.58.44018 Boehringer Ingelheim Investigational Site | London | |
| United Kingdom | 1182.58.44026 Boehringer Ingelheim Investigational Site | London | |
| United Kingdom | 1182.58.44027 Boehringer Ingelheim Investigational Site | London | |
| United Kingdom | 1182.58.44028 Boehringer Ingelheim Investigational Site | London | |
| United Kingdom | 1182.58.44031 Boehringer Ingelheim Investigational Site | London | |
| United Kingdom | 1182.58.44011 Boehringer Ingelheim Investigational Site | Peterborough | |
| United Kingdom | 1182.58.44022 Boehringer Ingelheim Investigational Site | Woolwich | |
| United Kingdom | 1182.58.44030 Boehringer Ingelheim Investigational Site | Woolwich | |
| United States | 1182.58.36 Suite 525 | Atlanta | Georgia |
| United States | 1182.58.15 | Boston | Massachusetts |
| United States | 1182.58.30 | Chapel Hill | North Carolina |
| United States | 1182.58.22 | Chicago | Illinois |
| United States | 1182.58.06 University of Cincinnati Medical Center, Infectious diseases | Cincinnati | Ohio |
| United States | 1182.58.01 Boehringer Ingelheim Investigational Site | Columbia | South Carolina |
| United States | 1182.58.18 University of Texas Southwest Medical Center at Dallas | Dallas | Texas |
| United States | 1182.58.19 Henry Ford Hospital | Detroit | Michigan |
| United States | 1182.58.08 | Honolulu | Hawaii |
| United States | 1182.58.07 | Houston | Texas |
| United States | 1182.58.04 Kansas City Free Health Clinic | Kansas City | Missouri |
| United States | 1182.58.02 Wellness Center | Las Vegas | Nevada |
| United States | 1182.58.29 | Los Angeles | California |
| United States | 1182.58.34 Campus Code 696446 | Los Angeles | California |
| United States | 1182.58.37 AIDS Health Care Foundation | Los Angeles | Connecticut |
| United States | 1182.58.42 Synergy Hematology/Oncology | Los Angeles | California |
| United States | 1182.58.43 | Los Angeles | California |
| United States | 1182.58.44 VW Hospital and Clinics | Madison | Wisconsin |
| United States | 1182.58.38 | Miami Beach | Florida |
| United States | 1182.58.10 Comprehensive Care Center | Nashville | Tennessee |
| United States | 1182.58.32 | New Orleans | Louisiana |
| United States | 1182.58.09 Polari Medical Group | New York | New York |
| United States | 1182.58.41 Circle Medical, LLC | Norwalk | Connecticut |
| United States | 1182.58.14 | Philadelphia | Pennsylvania |
| United States | 1182.58.20 University of Pittsburgh | Pittsburgh | Pennsylvania |
| United States | 1182.58.35 | Portland | Oregon |
| United States | 1182.58.039 Olmos Park Medical Associates | San Antonio | Texas |
| United States | 1182.58.03 | San Francisco | California |
| United States | 1182.58.33 Kaiser Permanente Medical Center, Clinical Trials Unit | San Francisco | California |
| United States | 1182.58.31 | Scottsdale | Arizona |
| United States | 1182.58.11 Swedish Medical Center | Seattle | Washington |
| United States | 1182.58.40 Drs. Raben and Feldman Research Associates | South Miami | Florida |
| United States | 1182.58.25 Wohl Clinic | St. Louis | Missouri |
| United States | 1182.58.23 Hillsborough County Health Department | Tampa | Florida |
| United States | 1182.58.28 | Washington | District of Columbia |
| Lead Sponsor | Collaborator |
|---|---|
| Boehringer Ingelheim |
United States, Australia, Belgium, Denmark, France, Greece, Ireland, Italy, Portugal, South Africa, Switzerland, United Kingdom,
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05454514 -
Automated Medication Platform With Video Observation and Facial Recognition to Improve Adherence to Antiretroviral Therapy in Patients With HIV/AIDS
|
N/A | |
| Completed |
NCT03760458 -
The Pharmacokinetics, Safety, and Tolerability of Abacavir/Dolutegravir/Lamivudine Dispersible and Immediate Release Tablets in HIV-1-Infected Children Less Than 12 Years of Age
|
Phase 1/Phase 2 | |
| Completed |
NCT03141918 -
Effect of Supplementation of Bioactive Compounds on the Energy Metabolism of People Living With HIV / AIDS
|
N/A | |
| Completed |
NCT03067285 -
A Phase IV, Open-label, Randomised, Pilot Clinical Trial Designed to Evaluate the Potential Neurotoxicity of Dolutegravir/Lamivudine/Abacavir in Neurosymptomatic HIV Patients and Its Reversibility After Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide. DREAM Study
|
Phase 4 | |
| Recruiting |
NCT04579146 -
Coronary Artery Disease (CAD) in Patients HIV-infected
|
||
| Completed |
NCT06212531 -
Papuan Indigenous Model of Male Circumcision
|
N/A | |
| Active, not recruiting |
NCT03256422 -
Antiretroviral Treatment Taken 4 Days Per Week Versus Continuous Therapy 7/7 Days Per Week in HIV-1 Infected Patients
|
Phase 3 | |
| Completed |
NCT03256435 -
Retention in PrEP Care for African American MSM in Mississippi
|
N/A | |
| Completed |
NCT00517803 -
Micronutrient Supplemented Probiotic Yogurt for HIV/AIDS and Other Immunodeficiencies
|
N/A | |
| Active, not recruiting |
NCT03572335 -
Systems Biology of Diffusion Impairment in Human Immunodeficiency Virus (HIV)
|
||
| Completed |
NCT04165200 -
Fecal Microbiota Transplantation as a Therapeutic Strategy for Patients Infected With HIV
|
N/A | |
| Recruiting |
NCT03854630 -
Hepatitis B Virus Vaccination in HIV-positive Patients and Individuals at High Risk for HIV Infection
|
Phase 4 | |
| Terminated |
NCT03275571 -
HIV, Computerized Depression Therapy & Cognition
|
N/A | |
| Completed |
NCT02234882 -
Study on Pharmacokinetics
|
Phase 1 | |
| Completed |
NCT01618305 -
Evaluating the Response to Two Antiretroviral Medication Regimens in HIV-Infected Pregnant Women, Who Begin Antiretroviral Therapy Between 20 and 36 Weeks of Pregnancy, for the Prevention of Mother-to-Child Transmission
|
Phase 4 | |
| Recruiting |
NCT05043129 -
Safety and Immune Response of COVID-19 Vaccination in Patients With HIV Infection
|
||
| Not yet recruiting |
NCT05536466 -
The Influence of Having Bariatric Surgery on the Pharmacokinetics, Safety and Efficacy of the Novel Non-nucleoside Reverse Transcriptase Inhibitor Doravirine
|
N/A | |
| Recruiting |
NCT04985760 -
Evaluation of Trimer 4571 Therapeutic Vaccination in Adults Living With HIV on Suppressive Antiretroviral Therapy
|
Phase 1 | |
| Completed |
NCT05916989 -
Stimulant Use and Methylation in HIV
|
||
| Terminated |
NCT02116660 -
Evaluation of Renal Function, Efficacy, and Safety When Switching From Tenofovir/Emtricitabine Plus a Protease Inhibitor/Ritonavir, to a Combination of Raltegravir (MK-0518) Plus Nevirapine Plus Lamivudine in HIV-1 Participants With Suppressed Viremia and Impaired Renal Function (MK-0518-284)
|
Phase 2 |